Utilize este identificador para referenciar este registo: https://hdl.handle.net/10316/107506
Título: Ugi Adducts of Isatin as Promising Antiproliferative Agents with Druglike Properties
Autor: Brandão, Pedro 
Puerta, Adrián
Padrón, José M.
Kuznetsov, Maxim L. 
Burke, Anthony J. 
Pineiro, Marta 
Palavras-chave: isatin; multicomponent reactions; Ugi reaction; Alzheimer’s disease; oxindole-lactam hybrids
Data: 2021
Editora: Wiley Online Library
Projeto: PD/BD/128490/2017–CATSUS 
UIDB/00313/2020 
UIDP/00313/2020 
UIDB/50006/2020 
Título da revista, periódico, livro ou evento: Asian Journal of Organic Chemistry (AsianJOC)
Volume: 10
Número: 12
Resumo: Molecular hybridization is a valuable approach in drug discovery. Combining it with multicomponent reactions is highly desirable, since structurally diverse libraries can be attained efficiently in an eco-friendly manner. In this work, isatin is used as key building block for the Ugi 4-center 3-component reaction synthesis of oxindole-lactam hybrids, under catalyst-free conditions. The resulting oxindole-β-lactam and oxindole-γ-lactam hybrids were evaluated for their potential to inhibit relevant central nervous system targets, namely cholinesterases and monoamine oxidases. Druglikeness evaluation was also performed, and compounds 4eca and 5dab exhibited great potential as selective butyrylcholinesterase inhibition, at the low micromolar range, with an interesting predictive pharmacokinetic profile. Our findings herein reported suggest oxindole-lactam hybrids as new potential agents for the treatment of Alzheimer’s disease.
URI: https://hdl.handle.net/10316/107506
ISSN: 2193-5807
2193-5815
DOI: 10.1002/ajoc.202100684
Direitos: embargoedAccess
Aparece nas coleções:I&D CQC - Artigos em Revistas Internacionais

Ficheiros deste registo:
Mostrar registo em formato completo

Citações SCOPUSTM   

6
Visto em 6/mai/2024

Citações WEB OF SCIENCETM

6
Visto em 2/mai/2024

Visualizações de página

63
Visto em 7/mai/2024

Downloads

40
Visto em 7/mai/2024

Google ScholarTM

Verificar

Altmetric

Altmetric


Este registo está protegido por Licença Creative Commons Creative Commons